324
Views
31
CrossRef citations to date
0
Altmetric
Research Article

Determination of reactive oxygen species associated with the degeneration of dopaminergic neurons during dopamine metabolism

, , , , &
Pages 249-257 | Received 08 Jul 2009, Published online: 17 Dec 2009

References

  • Pedrosa R, Soares-da-Silva P. Oxidative and non-oxidative mechanisms of neuronal cell death and apoptosis by L-3, 4-dihydroxyphenylalanine (L-DOPA) and dopamine. Br J Pharmacol 2002;137:1305–1313.
  • Ziv I, Melamed E, Nardi N, Luria D, Achiron A, Offen D, Barzilai A. Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons—a possible novel patho-genetic mechanism in Parkinson's disease. Neurosci Lett 1994;170:136–140.
  • Jones SR, Gainetdinov RR, Jaber M, Giros B, Wightman RM, Caron MG. Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc Natl Acad Sci USA 1998;95:4029–4034.
  • Hastings TG, Lewis DA, Zigmond MJ. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc Natl Acad Sci USA 1996;93:1956–1961.
  • Chen L, Ding Y, Cagniard B, Van Laar AD, Mortimer A, Chi W, Hastings TG, Kang UJ, Zhuang X. Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice. J Neurosci 2008;28:425–433.
  • Cohen G, Farooqui R, Kesler N. Parkinson disease: a new link between monoamine oxidase and mitochondrial electron flow. Proc Natl Acad Sci USA 1997;94:4890–4894.
  • Mallajosyula JK, Kaur D, Chinta SJ, Rajagopalan S, Rane A, Nicholls DG, Di Monte DA, Macarthur H, Andersen JK. MAO-B elevation in mouse brain astrocytes results in Parkinson's pathology. PLoS ONE 2008;3:e1616.
  • Rogoza RM, Fairfax DF, Henry P, N-Marandi S, Khan RF, Gupta SK, Mishra RK. Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia. Synapse 2004;54:156–163.
  • Anzai K, Aikawa T, Furukawa Y, Matsushima Y, Urano S, Ozawa T. ESR measurement of rapid penetration of DMPO and DEPMPO spin traps through lipid bilayer membranes. Arch Biochem Biophys 2003;415:251–256.
  • Liang Q, Smith AD, Pan S, Tyurin VA, Kagan VE, Hastings TG, Schor NF. Neuroprotective effects of TEMPOL in central and peripheral nervous system models of Parkinson's disease. Biochem Pharmacol 2005;70:1371–1381.
  • Yamato M, Egashira K, Utsumi H. Application of in vivo ESR spectroscopy to measurement of cerebrovascular ROS generation in stroke. Free Radic Biol Med 2003;35:1619–1631.
  • Willson RL. Reaction of triacetoneamine-N-oxyl with hydroxyl radicals. Int J Radiat Biol Relat Stud Phys Chem Med 1972;21:401–403.
  • Asmus KD, Nigam S. Kinetics of nitroxyl radical reactions. A pulse-radiolysis conductivity study. Int J Radiat Biol Relat Stud Phys Chem Med 1976;29:211–219.
  • Krishna MC, Grahame DA, Samuni A, Mitchell JB, Russo A. Oxoammonium cation intermediate in the nitroxide-catalyzed dismutation of superoxide. Proc Natl Acad Sci USA 1992;89:5537–5541.
  • Kudo W, Yamato M, Yamada K, Kinoshita Y, Shiba T, Watanabe T, Utsumi H. Formation of TEMPOL-hydroxylamine during reaction between TEMPOL and hydroxyl radical: HPLC/ECD study. Free Radic Res 2008;42:505–512.
  • Schmidt N, Ferger B. The biogenic trace amine tyramine induces a pronounced hydroxyl radical production via a monoamine oxidase dependent mechanism: an in vivo microdialysis study in mouse striatum. Brain Res 2004;1012:101–107.
  • Watanabe S, Fusa K, Takada K, Aono Y, Saigusa T, Koshikawa N, Cools AR. Effects of alpha-methyl-p-tyrosine on extracellular dopamine levels in the nucleus accumbens and the dorsal striatum of freely moving rats. J Oral Sci 2005;47:185–190.
  • Bobko AA, Kirilyuk IA, Grigor'ev IA, Zweier JL, Khramtsov VV. Reversible reduction of nitroxides to hydroxylamines: roles for ascorbate and glutathione. Free Radic Biol Med 2007;42:404–412.
  • Keston AS, Brandt R. The fliorometric analysis of ultramicro quantites of hydrogen peroxide. Anal Biochem 1965;11:1–5.
  • Milusheva E, Baranyi M, Kittel A, Sperlagh B, Vizi ES. Increased sensitivity of striatal dopamine release to H2O2 upon chronic rotenone treatment. Free Radic Biol Med 2005;39:133–142.
  • Ungerstedt U, Arbuthnott GW. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res 1970;24:485–493.
  • Ungerstedt U. Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour. Acta Physiol Scand Suppl 1971;367:49–68.
  • Juorio AV, Boulton AA. The effect of some precursor amino acids and enzyme inhibitors on the mouse striatal concentration of tyramines and homovanillic acid. J Neurochem 1982;39:859–863.
  • Bernheimer H, Hornykiewicz O. Decreased homovanillic acid concentration in the brain in Parkinsonian subjects as an expression of a disorder of central dopamine metabolism. Klin Wochenschr 1965;43:711–715.
  • Ehringer H, Hornykiewicz O. Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system. Klin Wochenschr 1960;38:1236–1239.
  • Nagatsu T, Kato T, Numata Y, Ikuta K, Sano M. Phenylethanolamine N-methyltransferase and other enzymes of catecholamine metabolism in human brain. Clin Chim Acta 1977;75:221–232.
  • Borges CR, Geddes T, Watson JT, Kuhn DM. Dopamine biosynthesis is regulated by S-glutathionylation. Potential mechanism of tyrosine hydroxylast inhibition during oxidative stress. J Biol Chem 2002;277:48295–48302.
  • Giustarini D, Rossi R, Milzani A, Colombo R, Dalle-Donne I. S-glutathionylation: from redox regulation of protein functions to human diseases. J Cell Mol Med 2004;8:201–212.
  • Oyagi A, Oida Y, Hara H, Izuta H, Shimazawa M, Matsunaga N, Adachi T, Hara H. Protective effects of SUN N8075, a novel agent with antioxidant properties, in in vitro and in vivo models of Parkinson's disease. Brain Res 2008;1214:169–176.
  • Dawson TM, Dawson VL. Molecular pathways of neuro-degeneration in Parkinson's disease. Science 2003;302:819–822.
  • Schapira AH, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD. Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1989;1:1269.
  • Glinka Y, Tipton KF, Youdim MB. Nature of inhibition of mitochondrial respiratory complex I by 6-Hydroxydopamine. J Neurochem 1996;66:2004–2010.
  • Glinka YY, Youdim MB. Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine. Eur J Pharmacol 1995;292:329–332.
  • Nicklas WJ, Vyas I, Heikkila RE. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sci 1985;36:2503–2508.
  • Saravanan KS, Sindhu KM, Mohanakumar KP. Acute intranigral infusion of rotenone in rats causes progressive biochemical lesions in the striatum similar to Parkinson's disease. Brain Res 2005;1049:147–155.
  • Tsang AH, Chung KK. Oxidative and nitrosative stress in Parkinson's disease. Biochim Biophys Acta 2009;1792:643–650.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.